Itoh et al., 1999 - Google Patents
The effect of neurotrophic pyrimidine heterocyclic compounds, MS-818 and MS-430, on the regeneration of injured peripheral nervesItoh et al., 1999
View PDF- Document ID
- 9103331872269837960
- Author
- Itoh S
- Samejima H
- Shinomiya K
- Awaya A
- Publication year
- Publication venue
- Restorative neurology and neuroscience
External Links
Snippet
The effects of pyrimidine heterocyclic compounds (MS-818 and MS-430) on nerve regeneration were evaluated using the cut-and-suture model of the right sciatic nerve of Wistar rats. After surgery, 1 or 5 mg/kg/day of MS-818 or MS-430 was intraperitoneally …
- 230000008929 regeneration 0 title abstract description 29
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cui et al. | CNTF, not other trophic factors, promotes axonal regeneration of axotomized retinal ganglion cells in adult hamsters. | |
| Frostick et al. | Schwann cells, neurotrophic factors, and peripheral nerve regeneration | |
| Gordon et al. | Experimental strategies to promote functional recovery after peripheral nerve injuries | |
| Boyd et al. | Glial cell line-derived neurotrophic factor and brain-derived neurotrophic factor sustain the axonal regeneration of chronically axotomized motoneurons in vivo | |
| Wells et al. | Gel matrix vehicles for growth factor application in nerve gap injuries repaired with tubes: a comparison of biomatrix, collagen, and methylcellulose | |
| Hirschberg et al. | Inflammation after axonal injury has conflicting consequences for recovery of function: rescue of spared axons is impaired but regeneration is supported | |
| Jubran et al. | Repair of peripheral nerve transections with fibrin sealant containing neurotrophic factors | |
| Hollowell et al. | Sciatic nerve regeneration across gaps within silicone chambers: long-term effects of NGF and consideration of axonal branching | |
| Sinson et al. | Nerve growth factor administration attenuates cognitive but not neurobehavioral motor dysfunction or hippocampal cell loss following fluid‐percussion brain injury in rats | |
| VARON et al. | Nerve growth factor in CNS repair | |
| Salvatierra et al. | Scopolamine disruption of septo-hippocampal activity and classical conditioning. | |
| Laird et al. | Acidic fibroblast growth factor stimulates motor and sensory axon regeneration after sciatic nerve crush in the rat | |
| Devesa et al. | Growth hormone treatment enhances the functional recovery of sciatic nerves after transection and repair | |
| Bodine‐Flower et al. | Time course of muscle atrophy and recovery following a phenol‐induced nerve block | |
| Choi et al. | Somatotopic organization of the facial nucleus is disrupted after lesioning and regeneration of the facial nerve: the histological representation of synkinesis | |
| Spector et al. | Rabbit facial nerve regeneration in NGF‐containing silastic tubes | |
| Navarro et al. | Effects of FK506 on nerve regeneration and reinnervation after graft or tube repair of long nerve gaps | |
| Hubner et al. | The threshold lowering effects of MDMA (ecstasy) on brain-stimulation reward | |
| Gu et al. | Survival, regeneration and functional recovery of motoneurons after delayed reimplantation of avulsed spinal root in adult rat | |
| Yildiz et al. | Efficacy of glial growth factor and nerve growth factor on the recovery of traumatic facial paralysis | |
| DE69635754T9 (en) | MEDICAMENTS FOR PREVENTING CONDITIONAL STENOSIS AS A RESULT OF NON-BYPASS INVASIVE INTERVENTION | |
| Itoh et al. | The effect of neurotrophic pyrimidine heterocyclic compounds, MS-818 and MS-430, on the regeneration of injured peripheral nerves | |
| Sulaiman et al. | Nerve surgery: a review and insights about its future | |
| AU2002231277B2 (en) | Neurotrophic tacrolimus analogs | |
| Hagg | Neurotrophic factors |